Increased ANGPT2 expression correlates with increased Gleason Score as well as with more invasive potential in other cancer types, such as disease progression of metastatic melanoma [29], metastasis to the lymph node of breast cancer [30, 31], and with worse prognosis and poor survival in lung cancer patients [32, 33]. This evidence concerns the gene ANGPT2 and metastatic melanoma.